# US 2020/0003770 A1 · Microparticle For Cultivating And Testing Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0003770 A1
- Document ID: US20200003770A1
- Status: Published application
- Kind: A1
- Application number: 16/490,804
- Filed: 2018-03-02
- Published: 2020-01-02
- Earliest claimed: 2017-03-03
- Assignees: Biomillenia SAS
- Applicants: Biomillenia SAS
- Inventors: Dirk Loeffert; Aleksander Dajkovic; Thomas Duboys
- Web page: https://patentgrep.com/patent/US20200003770A1

## CPC

- G01N 33/54306: {Solid-phase reaction mechanisms}
- C12N 5/0679: {Cells of the gastro-intestinal tract}
- C12Q 1/02: involving viable microorganisms
- C12N 2502/70: Non-animal cells
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Cultivation and/or test-system comprising at least two cultivation spaces combined in a microparticle, wherein the sperically shaped microparticle comprises, (i) a first cultivation space in the center core of said spherically shaped microparticle, (ii) a second cultivation space in the wall surrounding the core of said microparticle, (iii) wherein the wall surrounding the core allows for the exchange of molecules as, salts, nutrients, peptides, chemicals and other compounds in order for the cells in the first cultivation space to interact with the cells in second cultivation space and vice versa. In the test system, the cells are co-cultivated and the microparticles are then selected based on the phenotype of the cells in the first or second cultivation space.

## Claims

### Claim 1

Cultivation and/or test-system comprising at least two cultivation spaces combined in a microparticle, wherein the spherically shaped microparticle comprises
i) a first cultivation space in the center core of said spherically shaped microparticle,
ii) a second cultivation space in the wall surrounding the core of said microparticle,
wherein the wall surrounding the core allows for the exchange of molecules as, salts, nutrients, peptides, chemicals and other compounds in order for the cells in the first cultivation space to interact with the cells in the second cultivation space and vice versa, and
wherein the first cultivation space contains bacterial cells and the second cultivation space contains eukaryotic cells or vice versa.

### Claim 2 (depends on 1)

The system according to claim 1, wherein the bacterial cells are colon bacterial cells and the eukaryotic cells are epithelial colon cells.

### Claim 3 (depends on 1)

A method of co-cultivating and/or testing bacterial cells and eukaryotic cells together in a microparticle system according to claim 1, the method comprising the steps of:
i) co-cultivating said bacterial and eukaryotic cells in said microparticle system,
ii) giving the co-cultivated cells time to interact by means of compound diffusion between the two spaces,
iii) sorting said microparticles based on a phenotype of one or more groups of cells present in one or more of the microparticles, wherein the phenotype comprises a probiotic phenotype.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the probiotic phenotype of the one or more groups of cells is determined by detection of probiotic effects of the bacterial cells on the co-cultivated eukaryotic cells or vice versa.

### Claim 5 (depends on 3)

The method according to claim 3, wherein the probiotic effects are selected from the group comprising antimicrobial effects, antifungal effects, promotion of growth, immunomodulatory effects and neurological modulatory effects.

### Claim 6 (depends on 3)

The method according to claim 3, wherein the microparticles contain prebiotic substances.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the prebiotic substance is selected from the group comprising oligosaccharides, polysaccharides, fibers trans-galactooligosaccharide, inulin or any other substance having prebiotic effects on bacterial and/or eukaryotic cells.

### Claim 8 (depends on 3)

The method according to claim 3, wherein the probiotic effects of at least one or multiple bacterial strains isolated from natural samples comprising feces microbiome samples, gut microbiome samples, vaginal microbiome samples, soil microbiome samples and skin microbiome samples on eukaryotic cells comprising mammalian cells are analyzed.

### Claim 9 (depends on 3)

The method according to claim 3, wherein the analysis of probiotic effects of the co-cultivated cells in one microparticle is determined by means of cell proliferation assays, immunomodulatory assays, composition of different bacterial strains.

### Claim 10 (depends on 3)

The method according to claim 3, wherein the analysis of probiotic effects of the co-cultivated cells in one microparticle is determined by detection of specific substances selected from the group comprising cytokines, interleukins, leukotrienes, hormones, histamine, nitric oxide, neurotransmitters, muropeptides, oligosaccharides, teichoic acids, lipoteichoic acids, volatile fatty acids and lipoproteins.

### Claim 11 (depends on 3)

The method according to claim 3, wherein the sorting is done by ultrahigh-throughput flow systems, comprising microfluidics, millifluidics and FACS.

### Claim 12 (depends on 3)

The method according to claim 3, wherein up to 109 cells and at least 100 cells can be sorted in parallel.

### Claim 13 (depends on 3)

The method according to claim 3, wherein the first cultivation space contains 1,000,000 cells, more preferably 1,000 cells, even more preferably 100 cells, and most preferably no cells.

### Claim 14 (depends on 3)

The method according to claim 3, wherein the second cultivation space contains between 0 and 25,000 cells, at least 10 cells, more preferably 100 cells, even more preferably 500 cells, and most preferably 1,000 cells.

### Claim 15 (depends on 3)

The method according to claim 3, wherein the bacterial cells and the eukaryotic cells in the microparticles are co-cultivated for at least 12 hours, preferably 24 hours, and even more preferably 72 hours and/or up to two weeks before being sorted.

### Claim 16 (depends on 3)

The method according to claim 3, wherein the microparticles are cultivated in mixtures selected from the group comprising diluted soil samples, diluted feces, and microbial isolates from the vagina, nasopharynx, sinuses, skin or other natural samples.

### Claim 17 (depends on 3)

The method according to claim 3, wherein the microparticles include magnetic beads.

### Claim 18

Cultivation and/or test-system comprising at least two cultivation spaces combined in a microparticle, wherein the spherically shaped microparticle comprises
i) a first cultivation space in the center core of said spherically shaped microparticle,
ii) a second cultivation space in the wall surrounding the core of said microparticle,
wherein the wall surrounding the core allows for the exchange of molecules as, salts, nutrients, peptides, chemicals and other compounds in order to allow interaction between the cultivation spaces of said microparticle,
wherein the first and/or the second cultivation space contain bacterial cells, eukaryotic cells and/or prebiotic substances.

### Claim 19

Cultivation and/or test-system comprising at least two cultivation spaces combined in a microparticle, wherein the spherically shaped microparticle comprises
i) a first cultivation space in the center core of said spherically shaped microparticle,
ii) a second cultivation space in the wall surrounding the core of said microparticle,
wherein the wall surrounding the core allows for the exchange of molecules as, salts, nutrients, peptides, chemicals and other compounds in order to allow interaction between the cultivation spaces of said microparticle,
wherein the first cultivation space contains bacterial cells and/or eukaryotic cells, and the second cultivation space contains no cells or vice versa.
